Medscape November 11, 2019
GLASGOW — The promise of artificial intelligence (AI) to improve clinical decision-making and diagnose cancers earlier is on the horizon, with some successes already seen, but there remain a host of unanswered questions that have social and ethical implications, say experts.
During a dedicated session at the National Cancer Research Institute (NCRI) Cancer Conference 2019, the concept of AI and its application to diagnostics was explored from many angles, with real-world examples revealing the future for clinical care, and one study showing that the technology significantly improved cancer detection rates.
Still a Role for Humans
The optimism was nevertheless leavened with warnings over machine learning systems being only ever as good as the data they are built on, and the...
Today's Sponsors
Today's Sponsor